Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 28, 2017

AMH levels in girls with various pubertal problems

  • Senay Savas-Erdeve , Elif Sagsak , Meliksah Keskin EMAIL logo , Semra Cetinkaya and Zehra Aycan

Abstract

Background:

Anti-Müllerian hormone (AMH) is produced by granulosa cells surrounding follicles that have undergone recruitment from the primordial follicle pool but have not been selected for dominance (preantral and early antral follicles). In healthy girls, serum levels of AMH vary considerably between individuals. We aimed to evaluate the AMH level in girls with premature thelarche (PT) and central precocious puberty (CPP).

Methods:

Girls with CPP (n=21), PT (n=24) and a control prepubertal group (n=22) were included in the study.

Results:

AMH levels were significantly higher in the PT group than the prepubertal control group and similar to the CPP group. AMH levels in the CPP group were similar to the prepubertal control group. AMH levels showed a significant negative correlation with luteinizing hormone (LH), free testosterone and dehydroepiandrosterone sulphate (DHEAS) levels in the PT group. AMH levels were negatively correlated with height standard deviation score (HSDS), body mass index (BMI) SDS values and positively correlated with sex hormone binding globulin (SHBG) levels in the CPP group. These levels were positively correlated with SHBG levels in the control prepubertal group.

Conclusions:

Serum AMH levels in girls with PT was found to be higher than in prepubertal girls. AMH levels in the CPP group were not different compared with the PT and control groups.


Corresponding author: Dr. Meliksah Keskin, Dr. Sami Ulus Obstetrics and Gynecology and Pediatrics Training and Research Hospital, Pediatric Endocrinology Clinic, Altındağ/Ankara 06020, Turkey, Phone: +90-505-623-68-95, Fax: +90-312-317-03-53

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Raipert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, et al. Expression of anti-Müllerian hormone during and normal pathological gonadal development: association with differentiation of Sertoli and granulose cells. J Clin Endocrinol Metab 1999;84:3836–44.Search in Google Scholar

2. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571–6.Search in Google Scholar

3. Hagen CP, Aksglaede L, Sorensen K, Mouritsen A, Andersson AM, et al. Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod 2012;27:861–6.10.1093/humrep/der435Search in Google Scholar PubMed

4. Sahin NM, Kinik ST, Tekindal MA, Bayraktar N. AMH levels at central precocious puberty and premature thelarche: is it a parameter? J Pediatr Endocrinol Metab 2015;28:1351–6.10.1515/jpem-2014-0521Search in Google Scholar PubMed

5. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002; 246:1–190.Search in Google Scholar

6. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.10.1136/adc.44.235.291Search in Google Scholar PubMed PubMed Central

7. Hagen CP, Aksglaede L, Sorensen K, Main KM, Boas M, et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 2010;95:5003–10.10.1210/jc.2010-0930Search in Google Scholar PubMed

8. Codner E, Iniguez G, Hernandez IM, Lopez P, Rhumie HK, et al. Elevated anti-Müllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus. Clin Endocrinol (Oxf) 2011;74:73–8.10.1111/j.1365-2265.2010.03887.xSearch in Google Scholar PubMed

9. Aydın B, Winters SJ. Sex hormone-binding globulin in children and adolescents. J Clin Res Pediatr Endocrinol 2016;8:1–12.10.4274/jcrpe.2764Search in Google Scholar PubMed PubMed Central

10. Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC, et al. Association of anti-müllerian hormone levels with obesity in late reproductive-age women. Fertil Steril 2007;87:101–6.10.1016/j.fertnstert.2006.05.074Search in Google Scholar PubMed

11. Steiner AZ, Stanczyk FZ, Patel S, Edelman A. Anti-müllerian hormone and obesity: insights in oral contraceptive users. Contraception 2010;81:245–8.10.1016/j.contraception.2009.10.004Search in Google Scholar PubMed PubMed Central

12. Utriainen P, Jaaskelainen J, Voutilainen R. Serum anti-müllerian hormone concentrations in prepubertal girls with and without premature adrenarche: the influence of body mass index. Horm Res Paediatr 2010;74:207–11.10.1159/000282113Search in Google Scholar PubMed

Received: 2016-5-31
Accepted: 2016-12-19
Published Online: 2017-2-28
Published in Print: 2017-3-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 26.4.2024 from https://www.degruyter.com/document/doi/10.1515/jpem-2016-0217/html
Scroll to top button